Abstract:A subset of proliferation genes that are associated with origin licensing, firing, and DNA synthesis has been compared to known drivers of colon (COAD) and lung (LUAD) adenocarcinomas using Spearman's rank correlation coefficients. The frequency with which APC, CTNNB1, KRAS, MYC, Braf, TP53, Rb1, EGFR, and cell cycle components have direct or indirect co-expression with the proliferation factors permits identification of their expression relative to the G1-S phase of the cell cycle. Here, adenomatous polyposis coli (APC), a negative regulator of Wnt signaling known to function through MYC, indirectly co-expresses at the same frequency as proliferation genes in both COAD and LUAD, consistent with M phase expression. However, APC is indirectly co-expressed with MYC and is found mutated only in COAD. MYC is thought to function at the interface of transcription and replication, acting through the SWI/SNF chromatin remodeling complex, and increased or decreased expression of MYC can induce or repress tumorigenesis, respectively. These data suggest that transcription of APC during the M phase with low MYC co-expression contributes by an unknown mechanism to APC mutations and Wnt pathway deregulation in COAD and that upper and lower limits of MYC expression, enforced by the cell cycle, may influence cancer differentially. Other Wnt signaling components co-expressed in the low MYC context in COAD also have significantly higher mutation frequencies, supporting the hypothesis. Additionally, Braf is found here to have direct co-expression with multiple proliferation factors in non-EGFR activated LUAD, and EGFR-activated LUAD are completely deregulated with respect to E2F(s) 4/5/6 expression, potentially explaining the low proliferation rates seen in LUAD.Abbreviations: TCGA: The cancer genome atlas; PANCAN: Pan cancer; CDK: Cyclin-dependent kinase; COAD: Colon adenocarcinoma; LUAD: Lung adenocarcinoma; Wnt: Wingless/integrated signaling; MAPK: Mitogen-activated protein kinase; APC: Adenomatous polyposis coli gene; CIN: Chromosomal instability; GS: Genome stabile; MMR: Mismatch repair; mRNA: Messenger RNA; RPKM: Reads per kilobase of transcription per million mapped reads; RSEM: RNA Seq by expectation maximization; FDR: False discovery rate; GTEx: Genotype-Tissue Expression portal; MPF: Maturation-promoting factor; SCF: Skp1-Cul1-F-box; HH: Hedgehog; EMT: Epithelial mesenchymal transition; RB: Retinoblastoma; EGFR: Epidermal growth factor receptor; rs or ρ: Spearman's correlation.

Elevated Protein Expression of Cyclin D1 and Fra‐1 but Decreased Expression of C‐myc in Human Colorectal Adenocarcinomas Overexpressing Β‐catenin

[Expression of CD10 in Tumor-Associated Fibroblast of Cancerized or Recurrent Colorectal Adenomas].

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Expression of β-catenin, cyclin D1 and c-myc in colorectal carcinoma

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

C-Myc-induced Chemosensitization is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-Kappa B Activity in Pancreatic Cancer Cells.

Heterogeneous Expression and Association of Β‐catenin, P16 and C‐myc in Multistage Colorectal Tumorigenesis and Progression Detected by Tissue Microarray

Β-Catenin Expression is Altered in Dysplastic and Nondysplastic Aberrant Crypt Foci of Human Colon

Reduced Membranous and Ectopic Cytoplasmic Expression of Β ‐catenin Correlate with Cyclin D1 Overexpression and Poor Prognosis in Pancreatic Cancer

Clinical Significance of eIF4E and CyclinD1 Expression in Primary Colorectal Cancer

Beta- and Gamma-Catenin Mutations, but Not E-cadherin Inactivation, Underlie T-cell Factor/lymphoid Enhancer Factor Transcriptional Deregulation in Gastric and Pancreatic Cancer.

[Expression of Beta-Catenin in Human Colorectal Adenoma and Carcinoma].

Clinical significance and prognostic value of β-catenin expression in colonic adenocarcinoma

Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis

Study on expressions and clinical significance of β-catenin/c-myc by immunohistochemicalstaining to tissue microarrav in human colon cancer

Colocalization of β-catenin with Notch intracellular domain in colon cancer: a possible role of Notch1 signaling in activation of CyclinD1-mediated cell proliferation

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

Data from MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

The Histone Acetyltransferase GCN5 Expression is Elevated and Regulated by C-Myc and E2F1 Transcription Factors in Human Colon Cancer.

Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas

Expression of β-catenin and cyclinD1 in human pancreatic carcinoma and significance